• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Pharmaceuticals ETF

+ Add to Watchlist

XPH:US

103.9000 USD 1.5800 1.54%

As of 20:04:06 ET on 10/20/2014.

Snapshot for SPDR S&P Pharmaceuticals ETF (XPH)

Open: 102.1600 High - Low: 103.9000 - 102.1600 Primary Exchange: NYSE Arca
Volume: 60,144 52-Week Range: 76.6698 - 109.5600 Beta vs SPSIPHTR: 1.0020

ETF Chart for XPH

No chart data available.
  • XPH:US 103.9000
  • 1D
  • 1M
  • 1Y
102.3200
Interactive XPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XPH

SPDR Pharmaceuticals ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Pharmaceuticals Select Industry Index, an equal-weighted index.

Inception Date: 2006-06-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XPH

NAV (on 2014-10-20) 103.8737
Assets (M) (on 2014-10-20) 966.0394
Shares out (M) 9.30
Market Cap (M) 966.28
% Premium 0.03
Average 52-Week % Premium 0.0139
Fund Leveraged N

Dividends for XPH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.2387
Dividend Yield (ttm) 1.86%

Performance for XPH

1-Month -3.58% 1-Year +33.98%
3-Month +4.34% 3-Year +32.48%
Year To Date +18.69% 5-Year +25.39%
Expense Ratio 0.35

Top Fund Holdings for XPH

Filing Date: 10/20/2014
Name Position Value % of Total
Auxilium Pharmaceuticals Inc 1,423,377 43,541,102 4.513%
Avanir Pharmaceuticals Inc 3,210,906 37,503,382 3.887%
Impax Laboratories Inc 1,325,520 36,345,758 3.767%
Lannett Co Inc 808,641 35,515,513 3.681%
Mylan Inc/PA 679,906 34,206,071 3.546%
Allergan Inc/United States 189,037 33,884,882 3.512%
Akorn Inc 857,660 33,457,317 3.468%
Perrigo Co PLC 221,493 32,885,066 3.409%
Mallinckrodt PLC 370,970 32,330,036 3.351%
Horizon Pharma Plc 2,709,427 32,215,087 3.339%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil